The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $26.9 in the prior trading day, Kiniksa Pharmaceuticals International Plc (NASDAQ: KNSA) closed at $26.33, down -2.12%. In other words, the price has decreased by -$2.12 from its previous closing price. On the day, 0.62 million shares were traded. KNSA stock price reached its highest trading level at $26.97 during the session, while it also had its lowest trading level at $26.27.
Ratios:
Our goal is to gain a better understanding of KNSA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.16 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 43.94. For the most recent quarter (mrq), Quick Ratio is recorded 3.43 and its Current Ratio is at 3.66. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $40.
On September 13, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $40.
On May 03, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $34.Wells Fargo initiated its Overweight rating on May 03, 2024, with a $34 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 14 ’25 when Tessari Eben sold 18,900 shares for $28.72 per share. The transaction valued at 542,808 led to the insider holds 49,163 shares of the business.
Tessari Eben bought 18,900 shares of KNSA for $542,860 on Jul 14 ’25. On Jun 16 ’25, another insider, Tessari Eben, who serves as the CHIEF OPERATING OFFICER of the company, sold 17,300 shares for $28.28 each. As a result, the insider received 489,244 and left with 61,563 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KNSA now has a Market Capitalization of 1921326464 and an Enterprise Value of 1662900608. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.99 while its Price-to-Book (P/B) ratio in mrq is 4.19. Its current Enterprise Value per Revenue stands at 3.456 whereas that against EBITDA is -116.875.
Stock Price History:
The Beta on a monthly basis for KNSA is 0.12, which has changed by 0.007268548 over the last 52 weeks, in comparison to a change of 0.16932249 over the same period for the S&P500. Over the past 52 weeks, KNSA has reached a high of $30.69, while it has fallen to a 52-week low of $17.82. The 50-Day Moving Average of the stock is -5.70%, while the 200-Day Moving Average is calculated to be 12.56%.
Shares Statistics:
The stock has traded on average 772.24K shares per day over the past 3-months and 505400 shares per day over the last 10 days, according to various share statistics. A total of 42.16M shares are outstanding, with a floating share count of 40.49M. Insiders hold about 44.51% of the company’s shares, while institutions hold 55.70% stake in the company. Shares short for KNSA as of 1752537600 were 2533519 with a Short Ratio of 3.28, compared to 1749772800 on 2359063. Therefore, it implies a Short% of Shares Outstanding of 2533519 and a Short% of Float of 6.510000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
